Title : Subclinical involvement of the liver is associated with prognosis in treatment naive cancer patients - Pavo_2017_Oncotarget_8_81250 |
Author(s) : Pavo N , Raderer M , Goliasch G , Wurm R , Strunk G , Cho A , Novak JF , Gisslinger H , Steger GG , Hejna M , Kostler W , Zochbauer-Muller S , Marosi C , Kornek G , Auerbach L , Schneider ST , Parschalk B , Scheithauer W , Pirker R , Kiesewetter B , Pacher R , Zielinski C , Hulsmann M |
Ref : Oncotarget , 8 :81250 , 2017 |
Abstract :
BACKGROUND: Routinely tested liver biomarkers as alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT), butyryl-cholinesterase (BChE), albumin and bilirubin are altered in distinct malignancies and hepatic metastases. This study aimed to investigate whether all liver parameters have the ability to predict long-term mortality in treatment naive cancer patients but without a malignant hepatic involvement. |
PubMedSearch : Pavo_2017_Oncotarget_8_81250 |
PubMedID: 29113384 |
Pavo N, Raderer M, Goliasch G, Wurm R, Strunk G, Cho A, Novak JF, Gisslinger H, Steger GG, Hejna M, Kostler W, Zochbauer-Muller S, Marosi C, Kornek G, Auerbach L, Schneider ST, Parschalk B, Scheithauer W, Pirker R, Kiesewetter B, Pacher R, Zielinski C, Hulsmann M (2017)
Subclinical involvement of the liver is associated with prognosis in treatment naive cancer patients
Oncotarget
8 :81250
Pavo N, Raderer M, Goliasch G, Wurm R, Strunk G, Cho A, Novak JF, Gisslinger H, Steger GG, Hejna M, Kostler W, Zochbauer-Muller S, Marosi C, Kornek G, Auerbach L, Schneider ST, Parschalk B, Scheithauer W, Pirker R, Kiesewetter B, Pacher R, Zielinski C, Hulsmann M (2017)
Oncotarget
8 :81250